Glaucoma

  • Alphagan P 2021 report

    Alphagan P 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this...

  • Combigan 2021 report

    Combigan 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Durysta 2021 report

    Durysta 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 20 Pages The 5 Key Questions Addressed by this Report:...

  • Lumigan 2021 report

    Lumigan 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Rhopressa 2021 report

    Rhopressa 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Rocklatan 2021 report

    Rocklatan 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Vyzulta 2021 report

    Vyzulta 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Xelpros 2021 report

    Xelpros 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Zioptan 2021 report

    Zioptan 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Alrex 2020 report

    Alrex 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Cotempla XR-ODT 2020 report

    Cotempla XR-ODT 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 24 Pages The 5 Key Questions Addressed by this...

  • Lynparza 2020 report

    Lynparza 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 25 Pages The 5 Key Questions Addressed by this Report:...